JMT108 Injection

JMT-108 · Shanghai JMT-Bio Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JMT108 Injection, covering 2026-01-07 to 2026-01-07. Get the full timeline:

Most recent: Clinical Trial Update: Phase I/II Clinical Study of JMT108 Injection for the Treatment of Advanced Malignant Melanoma [Phase 1, Phase 2]